Universe Pharmaceuticals income tax expense

$607M−73.1% · FY2024

Universe Pharmaceuticals (UPC) reported $607M in income tax expense for fiscal 2024, −73.1% year on year.

Universe Pharmaceuticals — Income tax expense, 2019–2024
Fiscal year	Income tax expense	Change	Filing
FY20242024-09-30	$607M	−73.1%	Open →
FY20232023-09-30	$2.3B	+276,305.3%	Open →
FY20222022-09-30	$815,322	−65.4%	Open →
FY20212021-09-30	$2.4M	−7.2%	Open →
FY20202020-09-30	$2.5M	+21.0%	Open →
FY20192019-09-30	$2.1M	—	Open →

Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2024 compound annual growth +210.5%

Income tax expense at companies of similar size

Full ranking by income tax expense →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Universe Pharmaceuticals income tax expense |url=https://companiesranked.com/en/company/universe-pharmaceuticals/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Universe Pharmaceuticals income tax expense. CompaniesRanked. https://companiesranked.com/en/company/universe-pharmaceuticals/income-tax-expense

BibTeX

@misc{companiesranked-en-company-universe-pharmaceuticals-income-tax-expense-2026,
  author       = {{CompaniesRanked}},
  title        = {{Universe Pharmaceuticals income tax expense}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/universe-pharmaceuticals/income-tax-expense}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001213900-26-009000 · January 29, 2026

{{cite web |title=Universe Pharmaceuticals income tax expense — 20-F (0001213900-26-009000) |url=https://www.sec.gov/Archives/edgar/data/1809616/000121390026009000/ea0273969-20f_universe.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-01-29}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Universe Pharmaceuticals overview